Intelliseq
PrivateLast Round
Series A
Mar 28, 2025
Total Funding Raised
$6.46M
Momentum Score
75 /100
Company Overview
Intelliseq is a biotechnology company that develops and provides a bioinformatics platform for automated analysis and interpretation of the human genome.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Healthcare Analytics, Biotechnology, Workflow Automation
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intelliseq Comps
Public and private peers based on sector, stage, and business model.
Intelliseq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 28, 2025 | ||||
| Seed | Nov 7, 2022 |
Key People
Founding team and executive leadership
Intelliseq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Unfold.vc | Series A, Seed |
| YouNick Mint | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 243% MoM, reaching 2K.
- Dec 20, 2025
Added Telostrand Laboratory, LLC. in Biotechnology/Life Sciences.
Intelliseq Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Intelliseq's valuation, stock price, and market status.
